Auranofin ≥98% (by NMR)

Supplier: BioVision

BIOV2219-50EA 276 EUR
BIOV2219-50 BIOV2219-10
Auranofin ≥98% (by NMR)
Auranofin

An anti-arthritic drug that inhibits various leukocyte activation pathways at multiple sites. Inhibits release of inflammatory mediators from human basophils, pulmonary mast cells and macrophages. Efficient inducer of mitochondrial membrane permeability transition through the inhibition of mitochondrial thioredoxin reductase (TrxR).


  • Inhibits human neutrophil 5-lipoxygenase
  • Inhibits IκB kinase (IKK) by modifying Cys179 of the IKKß subunit


Caution: For research use only. Not for use in humans.

Storage Temperature: Ambient
CAS Number: 34031-32-8

Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR